
CYP3A5 polymorphism and immunosuppression in renal transplant recipients
Author(s) -
ManishR Balwani,
Amit Pasari,
Priyanka Tolani,
Vijay Katekhaye
Publication year - 2022
Publication title -
journal of the nephrology society
Language(s) - English
Resource type - Journals
ISSN - 2949-7949
DOI - 10.4103/jtns.jtns_19_22
Subject(s) - tacrolimus , cyp3a5 , dosing , immunosuppression , pharmacokinetics , medicine , therapeutic index , pharmacology , pharmacogenetics , toxicity , renal transplant , genotype , drug , kidney , transplantation , biology , biochemistry , gene